Tian An China Investments Company Limited (SEHK:28) made an offer to acquire the remaining stake in China Medical & HealthCare Group Limited (SEHK:383) from its shareholders at HKD 0.89 per share on June 16, 2023. TACI will fund the offer from the unsecured facility provided by Lee and Cashplus. The CMH Independent Board Committee, comprising Gao Zhaoyuan, Zhang Jian and Xia Xiaoning, has been established to advise the CMH Independent Shareholders in relation to the terms and conditions of the CMH Offer. The offer is conditional to a minimum tender of 50% stake. As of August 31, 2023 The CMH Independent Board Committee recommends the shareholder to accept the offer. The condition of the CMH Offer had been fulfilled and the CMH Offer became unconditional in all respects on September 21, 2023. Transaction is expected to close on September 21, 2023. The offer will remain open for acceptance until on October 5, 2023. Emperor Securities Limited acted as financial advisor to China Medical & HealthCare Group Limited and Yu Ming Investment Management Limited acted as a financial advisor to Tian An China Investments Company Limited.

Tian An China Investments Company Limited (SEHK:28) completed the acquisition of 18.13% stake in China Medical & HealthCare Group Limited (SEHK:383) from its shareholders for approximately HKD 180 million on October 5, 2023. As part of the offer, valid acceptance of 196,860,010 CMH Offer Shares.